Skip to Main Content
Back to News

Insider Sale: Director at $THC Sells 3,952 Shares

Automated

Christopher S. Lynch, a director at $THC, sold 3,952 shares of the company on 08-19-2025 for an estimated $697,093. We received data on the trade from a recent SEC filing. This was a sale of approximately 24.2% of their shares of this class of stock. Following this trade, they now own 12,358 shares of this class of $THC stock.

$THC Insider Trading Activity

$THC insiders have traded $THC stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.

Here’s a breakdown of recent trading of $THC stock by insiders over the last 6 months:

  • JAMES L BIERMAN has made 0 purchases and 4 sales selling 20,000 shares for an estimated $3,249,258.
  • PAOLA M ARBOUR (EVP, Chief Information Officer) has made 0 purchases and 2 sales selling 14,199 shares for an estimated $2,373,726.
  • J ROBERT KERREY has made 0 purchases and 9 sales selling 15,748 shares for an estimated $2,138,986.
  • THOMAS W ARNST (EVP, Chief Admin. Officer & GC) sold 9,786 shares for an estimated $1,624,476
  • CHRISTOPHER S. LYNCH sold 3,952 shares for an estimated $697,093
  • RICHARD W FISHER has made 0 purchases and 2 sales selling 3,913 shares for an estimated $654,682.
  • CECIL D HANEY sold 2,500 shares for an estimated $310,650

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$THC Hedge Fund Activity

We have seen 308 institutional investors add shares of $THC stock to their portfolio, and 369 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • INVESCO LTD. removed 1,364,955 shares (-32.7%) from their portfolio in Q2 2025, for an estimated $240,232,080
  • BOSTON PARTNERS added 1,095,630 shares (+94.2%) to their portfolio in Q2 2025, for an estimated $192,830,880
  • NUVEEN, LLC removed 932,271 shares (-57.4%) from their portfolio in Q2 2025, for an estimated $164,079,696
  • ALLIANCEBERNSTEIN L.P. added 624,125 shares (+375.7%) to their portfolio in Q2 2025, for an estimated $109,846,000
  • ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 607,637 shares (-51.1%) from their portfolio in Q2 2025, for an estimated $106,944,112
  • PACER ADVISORS, INC. added 590,028 shares (+inf%) to their portfolio in Q2 2025, for an estimated $103,844,928
  • HOLOCENE ADVISORS, LP added 584,404 shares (+inf%) to their portfolio in Q2 2025, for an estimated $102,855,104

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$THC Congressional Stock Trading

Members of Congress have traded $THC stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $THC stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$THC Analyst Ratings

Wall Street analysts have issued reports on $THC in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Wells Fargo issued a "Overweight" rating on 08/14/2025
  • Barclays issued a "Overweight" rating on 07/24/2025
  • UBS issued a "Buy" rating on 07/23/2025
  • Raymond James issued a "Outperform" rating on 07/23/2025
  • Guggenheim issued a "Buy" rating on 07/23/2025
  • Truist Securities issued a "Buy" rating on 07/16/2025
  • Mizuho issued a "Outperform" rating on 07/11/2025

To track analyst ratings and price targets for $THC, check out Quiver Quantitative's $THC forecast page.

$THC Price Targets

Multiple analysts have issued price targets for $THC recently. We have seen 13 analysts offer price targets for $THC in the last 6 months, with a median target of $200.0.

Here are some recent targets:

  • Stephen Baxter from Wells Fargo set a target price of $200.0 on 08/14/2025
  • Benjamin Rossi from JP Morgan set a target price of $200.0 on 08/04/2025
  • Michael Ha from Baird set a target price of $167.0 on 07/25/2025
  • Andrew Mok from Barclays set a target price of $208.0 on 07/24/2025
  • Jason Cassorla from Guggenheim set a target price of $188.0 on 07/23/2025
  • A.J. Rice from UBS set a target price of $238.0 on 07/23/2025
  • John Ransom from Raymond James set a target price of $200.0 on 07/23/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles